Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of SOM230(PasireotideLAR) and Topotecan in Patients With Relapsed or Refractory Small Cell Lung Cancer

NCT01417806 is registered in ClinicalTrials.gov with South Florida Veterans Affairs Foundation for Research and Education as lead sponsor.

NCT NCT01417806
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01417806 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of SOM230(PasireotideLAR) and Topotecan in Patients With Relapsed or Refractory Small Cell Lung Cancer
Lead sponsor
South Florida Veterans Affairs Foundation for Research and Education
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2011
Completion date
December 31, 2016
Enrollment
28 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

small cell lung cancer